Loading...

IPCALAB Ipca Laboratories Ltd Disposals and divestitures Announcement

pc L

PCLB

Ipca Laboratories Ltd

(IPCALAB)

2025 Announcement

Share Transfer Notice

Trading window closure

Conference Call Transcript

Conference Call Outcome

Newspaper publication of un...

Unaudited Financials

Board Meeting Outcome

Geographic expansion

FDA inspection status

Analyst / Investor Meet

Board Meeting Intimation

Board Meeting for Results

Regulatory Compliance

Equity Disinvestment

Disinvestment in Bayshore

Regulatory Compliance

Trading window closure (ins...

Form 483 observations

Registrar Update

Volume Movement Clarification

Newspaper publication of re...

Conference Call Outcome

Unaudited Q2 Results

Unaudited results

Conference Call

Unit Sale Announcement

Unit Sale Announcement

Board Meeting Notice

New Subsidiary in Germany

Re-lodgment Notice

Compliance Certificate

Tech Transfer Agreement

Transfer Request Re-lodgement

Shareholder Notice

Investor Call Outcome

Conference Call Link

Financial Results

Shareholder Notification

AGM Notice Issued

Compliance Certificate

Credit Rating Affirmed

GST Order Received

Management Change

Analyst Meeting

Audit Firm Name Change

Share Transfer Notice

Earnings Call Transcript

Conference Call Link

Financial Results Published

Secretarial Compliance

Memorandum Amendments

Unichem Acquisition

Compliance Certificate

Manufacturing Unit Sale

Management Change

Investor Call Summary

Financial Results Notice

Conference Call Update

Investor Conference Call

CGST Order Received

Tax Order Received

CGST Orders Received

GST Demand Order

Compliance Certificate

Name Change RTA

Subsidiary Closure

Dividend Record Date

Dividend Record Date

Earnings Conference Call

Financial Results

Conference Call Update

Earnings Call Announcement

Interim Dividend Announcement

Dividend Record Date

Regulatory Certificate

Business Consolidation

Equity Shares Transfer

Director Departure

Tax Demand Appeal

Earnings Call Recap

Conference Call Update

Director Appointments

Financial Results Publication

Conference Call Announcement

Launch of Diulcus(r)

Notice of meeting

Credit Rating Update

Superannuation Announcement

Certificate Submission

Fine upheld by Court of Jus...

Conference Call Outcome

Investor Conference Call

Financial Results Published

Annual Compliance Report

Director Appointment

Investor Conference

Certificate Submission

Investment Update

Compliance Certificate Conf...

Director Change

Technology Transfer Agreement

Postal Ballot Notice

Earnings Conference Call

Conference Call

Financial Results Published

Change in Directorate

Conference Call

Certificate Submission

Financial Results Published

Conference Call Outcome

Conference Call

Dividend Record Date Announ...

Conference Call

US FDA Inspection

Dividend Date Revision

US FDA Inspection - VAI Cla...

Certificate Submission

Acquisition of Unichem Labo...

Inspection result

Earnings Call Conference

Financial Statements

Investor Meetings

Asset Acquisitions

Asset Acquisitions

Asset Acquisitions

Merger of Equals

Financial Statements

Financial Statements

Primary Offerings

Form 483 with Observations

Regulatory Action

Regulatory Compliance

Financial Statements Public...

Conference Cancellation

Related Party Transactions

Asset Acquisitions

Merger of Equals

External Links:

Data:

Ipca Laboratories Ltd has approved the sale of its APIs and drug intermediates manufacturing unit in Ankleshwar to Suleshvari Pharma Pvt. Ltd. for Rs. 22.15 crores, with completion expected by December 31, 2025. This unit generated Rs. 50.24 crores in revenue in the last financial year, accounting for just 0.74% of the company's total income, and the sale is not expected to materially impact the company's business.

AI Assistant

Ipca Laboratories Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.